MedPath

A randomized, double-blind, placebo-controlled study of Jieyu Xifeng Decoction in the treatment of anxiety insomnia

Phase 1
Conditions
Insomnia comorbid anxiety disorder
Registration Number
ITMCTR2000003796
Lead Sponsor
Shanghai Hospital of traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. According to the diagnostic criteria of Western medicine for insomnia;
2. According to the TCM diagnostic criteria of insomnia;
3. The age is 18-70 years old;
4. PSQI score > 11, Spiegel Sleep Scale (improved) score > 12,HAMA score >= 14, and HAMA < 30;
5. No traditional Chinese medicine or western medicine was used to treat insomnia symptoms in the past month, or other drugs were taken in a short time (1 week), but no effect was found;
6. Those who voluntarily participate in this clinical study, are willing to receive treatment in accordance with the prescribed course of treatment, and can sign informed consent.

Exclusion Criteria

1. Patients with depression, severe anxiety, bipolar disorder, schizophrenia, aphasia and other serious, neuropsychiatric diseases, accompanied by thyroid function, hypertension, coronary heart disease and with serious heart, liver, kidney or other serious organic damage disease;
2. Pregnant and lactating women;
3. Subjects taking sleeping pills, antidepressants, etc.;
4. Those who fail to treat according to the specified requirements, and fill in incomplete information, etc. can not accurately judge the curative effect.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
HAMA score;PSQI score;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath